Change in the Neutrophil-to-Lymphocyte Ratio (NLR) Pre and Post Stereotactic Body Radiation Treatment (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC): Is There a Clinical Significance?

被引：0
|
作者：
Chung, E. [1 ]
Biswas, T. [2 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[2] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.1833
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TU_27_3585
引用
收藏
页码：E679 / E679
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of neutrophil-to-lymphocyte ratio (NLR) pre and post chemoradiotherapy (CRT) in stage III non-small cell lung cancer (NSCLC)
    Palomar Abril, V.
    Soria-Comes, T.
    Martin Ureste, M.
    Maestu Maiques, I.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [2] Use of the neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR) for prognostication of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT): a systematic review
    Sit, Daegan
    Raissi, Thomas
    Giuliani, Meredith
    Lee, Percy
    Shaverdian, Narek
    Walker-Dilks, Cindy
    Swaminath, Anand
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2019, 8 (01) : 13 - 21
  • [3] Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC)
    Vitorino, M.
    Tomas, T.
    Almeida, S.
    Silva, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S793 - S794
  • [4] Prognostic Impact of Neutrophil-to-Lymphocyte Ratio (NLR) for Advanced Non-Small Cell Lung Cancer
    Ishihara, M.
    Ochiai, R.
    Haruyama, T.
    Tagami, Y.
    Sakamoto, T.
    Tanzawa, S.
    Honda, T.
    Ota, S.
    Ichikawa, Y.
    Watanabe, K.
    Seki, N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S389 - S389
  • [5] Utilization of Pre- and Post-Stereotactic Body Radiotherapy (SBRT) Neutrophil-to-Lymphocyte (NLR) Ratios and Platelet-to-Lymphocyte (PLR) Ratios as Prognostic Factors in Early-Stage Non-Small Cell Lung Cancer
    Sharma, N.
    Podder, T.
    Biswas, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E19 - E19
  • [6] Prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in advanced non-small cell lung cancer
    Adamowicz, K.
    Romanowska, A.
    Zaucha, R. E.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [7] Prognostic significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors
    Amaral, S. R.
    Casal Moura, M.
    Carvalho, J.
    Chaves, A.
    Jesus, E.
    Sousa, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [8] Changes in Volumes of Stage I Non-small Cell Lung Cancer (NSCLC) During Stereotactic Body Radiation Therapy (SBRT)
    Tatekawa, K.
    Iwata, H.
    Kawaguchi, T.
    Baba, F.
    Otsuka, S.
    Miyakawa, A.
    Iwana, M.
    Tamura, T.
    Shibamoto, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S576 - S577
  • [9] Stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC)
    Dahele, M.
    Pearson, S.
    Franks, K.
    Purdie, T.
    Bissonnette, J.
    Brade, A. M.
    Cho, J.
    Sun, A.
    Jaffray, D.
    Bezjak, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Can the Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) Predict Survival or Local Control in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC)? A Systematic Review
    Sit, D.
    Thomas, R.
    Giuliani, M. E.
    Lee, P.
    Shaverdian, N.
    Walker, C.
    Swaminath, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E706 - E707
12345